Druggability of Coronary Artery Disease Risk Loci

BACKGROUND: Genome-wide association studies (GWAS) have identified multiple loci associated with coronary artery disease (CAD) and myocardial infarction (MI), but only a few of these loci are current targets for on-market medications. To identify drugs suitable for repurposing and their targets, we...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Circ Genom Precis Med
Autors principals: Tragante, Vinicius, Hemerich, Daiane, Alshabeeb, Mohammad, Brænne, Ingrid, Lempiainen, Harri, Patel, Riyaz, den Ruijter, Hester M., Barnes, Michael R., Moore, Jason H., Schunkert, Heribert, Erdmann, Jeanette, Asselbergs, Folkert W.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6205215/
https://ncbi.nlm.nih.gov/pubmed/30354342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCGEN.117.001977
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars